← All organizations

S-Biotek

For profitWebsite ↗

Also known as: SBiotek

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 1

First clinical trial

Last known activity

Feb 1, 2009

Acquired by Agilent Technologies, Inc. on Jul 11, 2019

Timeline

2000s

Jun 1, 2008
S-Biotek— Founded

2010s

Jul 11, 2019
Agilent Technologies, Inc.— Acquired By

Drugs by trial phase (1 distinct, 1 trials)

Phase 1 (1 own, 0 via acquisition)

sodium alginate

Indications

Studied for

Overweight

Recent trials (1)

NCT01101633CollaboratorPhase 1Feb 1, 2009

Details

Founded: Copenhagen, DK Jun 1, 2008
Last known activity: Feb 1, 2009